GTCR LLC

GTCR LLC is a prominent American private equity firm established in 1980, headquartered in Chicago, Illinois, with additional offices in New York and West Palm Beach. The firm's core business revolves around leveraged buyouts, leveraged recapitalizations, growth capital, and rollup transactions. GTCR is known for pioneering "The Leaders Strategy™," an investment approach focused on identifying and partnering with experienced management leaders in specific sectors to acquire and build market-leading companies through both organic growth and strategic acquisitions.

GTCR primarily invests in high-growth industries, including Financial Services & Technology, Healthcare, Technology, Media & Telecommunications (or Information Services & Technology), and Business & Consumer Services. The firm's investment strategy emphasizes a "buy-and-build" approach, often involving platform acquisitions followed by strategic add-ons to enhance portfolio company value. Since its inception, GTCR has invested over $35 billion in more than 300 companies and currently manages approximately $45 billion in equity capital.

Under the leadership of Co-CEOs Dean Mihas and Collin Roche, GTCR continues to be an active player in the private equity landscape. Recent notable activities include the divestiture of Corza Medical's Biosurgery Business Unit in July 2026, and significant acquisitions in April 2026, such as the Fiduciary Trust Company and European generics pharmaceutical company Zentiva. In April 2026, the firm launched its fifteenth flagship fund, GTCR Fund XV, targeting between $13 billion and $14 billion. As of December 31, 2025, GTCR managed approximately $48.6 billion in total assets.